Initial public offer of 27,60,000 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Hemant Surgical Industries Limited ("The Company" or "HSIL" or "The Issuer") at an issue price of Rs. 90/- per equity share for cash, aggregating up to Rs. 24.84 crores ("Public Issue") out of which 1,44,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 90/- per equity share for cash, aggregating Rs. 1.30 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 26,16,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 90/- per equity share for cash, aggregating upto
Rs. 23.54 crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.44% and 25.06% respectively of the post-issue paid-up equity share capital of the company.
*Subject to finalization of basis of allotment.
The face value of the equity shares is Rs. 10/- each. The issue price is 9.0 times with the face value of the equity shares. The anchor investor issue price is Rs. 90 per equity share.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
24-May-2023
26-May-2023
₹ 90.00
₹ 0.00
Minimum Application for shares in Nos : 1600.0
Further Multiples of : 1600.0
(₹)Cr.
Lead Managers to the Issue
Project Cost
20.65
Hem Securities Ltd
Project Financed through Current Offer
24.84
Post Issue Equity Share Capital
10.44
Issue Price
₹90.00
Projects
Funding capital expenditure towards installation of additional plant and machinery